Cyclophosphamide (CY) Conditioning In Patients with Severe Aplastic Anaemia (SAA) Given Unrelated Marrow Transplantation: Final Results of a Phase 1-2 Dose De-Escalation Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0301; NCT 00326417)

被引：0
|
作者：
Anderlini, P. [1 ]
Wu, J. [2 ]
Deeg, H. J. [3 ]
Gersten, I. [2 ]
Ewell, M. [2 ]
Tolar, J. [4 ]
Antin, J. [5 ]
Arai, S. [6 ]
Horwitz, M. [7 ]
McCarty, J. [8 ]
Nakamura, R. [9 ]
Pulsipher, M. [10 ]
Adams, R. [11 ]
Leifer, E. [12 ]
DiFronzo, N. [13 ]
Horowitz, M. H. [14 ]
Confer, D. [15 ]
Eapen, M. [14 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Stem Cell Transplantat, Houston, TX 77030 USA
[2] EMMES Corp, Rockville, MD USA
[3] FHCRC, Seattle, WA USA
[4] Univ Minnesota, Minneapolis, MN USA
[5] Dana Farber Canc Ctr, Boston, MA USA
[6] Stanford Hosp & Clin, Stanford, CA USA
[7] Duke Univ, Durham, NC USA
[8] Virginia Commonwealth Univ, Richmond, VA USA
[9] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
[10] Childrens Hosp, Los Angeles, CA 90027 USA
[11] Phoenix Childrens Hosp, Phoenix, AZ USA
[12] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA
[13] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA
[14] CIBMTR, Milwaukee, WI USA
[15] NMDP, Minneapolis, MN USA
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P706
引用
收藏
页码：S492 / S493
页数：2
相关论文
共 10 条
  • [1] Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study
    Anderlini, Paolo
    Wu, Juan
    Gersten, Iris
    Ewell, Marian
    Tolar, Jakob
    Antin, Joseph H.
    Adams, Roberta
    Arai, Sally
    Eames, Gretchen
    Horwitz, Mitchell E.
    McCarty, John
    Nakamura, Ryotaro
    Pulsipher, Michael A.
    Rowley, Scott
    Leifer, Eric
    Carter, Shelly L.
    DiFronzo, Nancy L.
    Horowitz, Mary M.
    Confer, Dennis
    Deeg, H. Joachim
    Eapen, Mary
    LANCET HAEMATOLOGY, 2015, 2 (09): : E367 - E375
  • [2] Optimized Cyclophosphamide (CY) Dosing in Combination with Fludarabine, TBI and ATG As Conditioning for Unrelated Donor Bone Marrow Transplantation (BMT) in Severe Aplastic Anemia (SAA): A Phase I/II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
    Anderlini, Paolo
    Wu, Juan
    Deeg, H. Joachim
    Gersten, Iris
    Ewell, Marian
    Tolar, Jakub
    Antin, Joseph H.
    Arai, Sally
    Horwitz, Mitchell E.
    McCarty, John M.
    Nakamura, Ryotaro
    Pulsipher, Michael A.
    Adams, Roberta H.
    Leifer, Eric
    Carter, Shelly L.
    DiFronzo, Nancy L.
    Horowitz, Mary M.
    Confer, Dennis L.
    Eapen, Mary
    BLOOD, 2014, 124 (21)
  • [3] Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)
    Kamani, Naynesh R.
    Walters, Mark C.
    Carter, Shelly
    Aquino, Victor
    Brochstein, Joel A.
    Chaudhury, Sonali
    Eapen, Mary
    Freed, Brian M.
    Grimley, Michael
    Levine, John E.
    Logan, Brent
    Moore, Theodore
    Panepinto, Julie
    Parikh, Suhag
    Pulsipher, Michael A.
    Sande, Jane
    Schultz, Kirk R.
    Spellman, Stephen
    Shenoy, Shalini
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (08) : 1265 - 1272
  • [4] Results of the Blood and Marrow Transplant Clinical Trials Network Study BMT CTN 0601: Scurt - a Multicenter Phase II Trial of Unrelated Donor Reduced Intensity Bone Marrow Transplantation (BMT) for Children with Severe Sickle Cell Disease
    Shenoy, Shalini
    Eapen, Mary
    Wu, Juan
    Walters, Mark C.
    Levine, John E.
    Logan, Brent R.
    Gersten, Iris D.
    Kamani, Naynesh R.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S104 - S104
  • [5] A Multicenter Phase II Trial of Unrelated Donor Reduced Intensity Bone Marrow Transplantation for Children with Severe Sickle Cell Disease (SCURT): Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0601) Study
    Shenoy, Shalini
    Eapen, Mary
    Wu, Juan
    Walters, Mark C.
    Levine, John E.
    Logan, Brent
    Gersten, Iris D.
    Kamani, Naynesh R.
    BLOOD, 2015, 126 (23)
  • [6] PHASE II TRIAL OF NON-MYELOABLATIVE CONDITIONING (NST) DOUBLE UMBILICAL CORD BLOOD TRANSPLANTATION (DUCBT) FROM UNRELATED DONORS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES: RESULTS OF BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK (BMT CTN) PROTOCOL 0604
    Brunstein, C. G.
    Carter, S.
    Fuchs, E. J.
    Karanes, C.
    Devine, S.
    Aljitawi, O.
    Cutler, C.
    Ballen, K. K.
    Thompson, J.
    O'Donnell, P., V
    Eapen, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S151 - S151
  • [7] UNRELATED DONOR CORD BLOOD TRANSPLANTATION FOR CHILDREN WITH SEVERE SICKLE CELL DISEASE: RESULTS OF A PHASE II STUDY FROM THE BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK
    Kamani, N. R.
    Walters, M.
    Carter, S.
    Brochstein, J. A.
    Eapen, M.
    Levine, J. E.
    Logan, B.
    Panepinto, J.
    Parikh, S.
    Pulsipher, M.
    Schultz, K. R.
    Shenoy, S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S326 - S326
  • [8] PHASE II TRIAL OF NON-MYELOABLATIVE CONDITIONING AND PARTIALLY HLA-MISMATCHED (HLA-HAPLOIDENTICAL) BONE MARROW TRANSPLANTATION (BMT) FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES: RESULTS OF BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK (BMT CTN) PROTOCOL 0603
    Fuchs, E. J.
    Wu, J.
    Carter, S.
    Brunstein, C. G.
    Costa, L. J.
    Wingard, J. R.
    Jagasia, M.
    D'Elia, J.
    Eapen, M.
    O'Donnell, P., V
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S151 - S151
  • [9] Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901
    Scott, Bart L.
    Pasquini, Marcelo C.
    Logan, Brent
    Wu, Juan
    Devine, Steve
    Porter, David L.
    Maziarz, Richard T.
    Warlick, Erica
    Fernandez, Hugo F.
    Alyea, Edwin P.
    Hamadani, Mehdi
    Bashey, Asad
    Giralt, Sergio A.
    Leifer, Eric
    Geller, Nancy
    Le-Rademacher, Jennifer
    Mendizabal, Adam M.
    Horowitz, Mary M.
    Deeg, H. Joachim
    Horwitz, Mitchell E.
    BLOOD, 2015, 126 (23)
  • [10] Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502
    Devine, Steven M.
    Owzar, Kouros
    Blum, William
    Mulkey, Flora
    Stone, Richard M.
    Hsu, Jack W.
    Champlin, Richard E.
    Chen, Yi-Bin
    Vij, Ravi
    Slack, James
    Soiffer, Robert J.
    Larson, Richard A.
    Shea, Thomas C.
    Hars, Vera
    Sibley, Alexander B.
    Giralt, Sergio
    Carter, Shelly
    Horowitz, Mary M.
    Linker, Charles
    Alyea, Edwin P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (35) : 4167 - +
1